Category: Clinical TrialsSyndicate content

IlluminOss wins FDA nod for bone fracture device trial

November 19, 2014 by Val Kennedy

IlluminOss Medical says the FDA cleared a clinical trial of its photodynamic bone stabilization system for treating upper arm fractures due to metastatic cancer.

IlluminOss wins FDA nod for bone fracture device trial

IlluminOss Medical said the FDA granted "conditional" clearance for a clinical trial of its photodynamic bone stabilization system, ahead of its bid for de novo clearance from the watchdog agency.

Boston Scientific: Our new Synergy stent is as good as Promus

November 19, 2014 by Brad Perriello

Boston Scientific's Synergy bioabsorbable polymer stent passes the Evolve II pivotal trial with flying colors.

Boston Scientific: Our new Synergy stent is as good as Promus

Study: St. Jude Medical's CardioMEMS device slashes readmission rates

November 19, 2014 by Brad Perriello

St. Jude Medical's CardioMEMS heart failure monitor slashes 30-day hospital readmission rates in Medicare-eligible patients, according to an analysis of data from St. Jude's Champion trial.

Study: St. Jude Medical's CardioMEMS device slashes readmission rates

DaVita, Medtronic to study arrhythmia in dialysis patients

November 17, 2014 by Val Kennedy

Cardiac device-maker Medtronic and dialysis-provider DaVita Healthcare Partners plan to team up to identify and study cardiac arrhythmia in patients undergoing dialysis.

DaVita, Medtronic to study arrhythmia in dialysis patients

Covidien study: VenaSeal effective in treating leg veins

November 17, 2014 by Val Kennedy

A Covidien study has shown that its new VenaSeal system is just as effective in treating chronic leg vein disorders as its ClosureFast ablation catheter.

Covidien study: VenaSeal effective in treating leg veins

Study: Stent patients benefit from long-term blood thinners

November 17, 2014 by Brad Perriello

Stent patients with coronary artery disease may benefit from long-term treatment with blood thinners, according to the 10,000-subject drug-eluting stent arm of the Dual Anti-Platelet Therapy study.

Study: Stent patients benefit from long-term blood thinners

Patients implanted with a drug-eluting stent who have coronary artery disease may benefit from dual anti-platelet therapy for longer than the standard year, according to the landmark DAPT study of 10,000 DES patients.

Medtronic: Hemodialysis patients at risk for arrhythmia

November 14, 2014 by Val Kennedy

A Medtronic study shows hemodialysis patients experience significantly higher-than-expected rates of arrhythmia and that the episodes appeared to coincide with their treatment cycles.

Medtronic: Hemodialysis patients at risk for arrhythmia

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Preferred Vendors

SMC Ltd. (Scientific Molding Corp.)
Manufactures injection-molded, single-use disposable medical devices
Tegra Medical
Provides contract manufacturing and assembly services
CB Set: Concord Biomedical Sciences and Emerging Technologies
Provides research support for all phases of biomedical discovery and development research.
Admet
Static and Dynamic testing systems for materials, components, and devices. Systems range from 50 grams to 600kN of force capacity in tension, compression, torsion, and more.
Provides grips, fixtures, heating and cooling systems, and fluid baths.
Proven Process Medical Devices
Provides R&D and contract manufacturing servics
AdvancedCath
Finished Guidewires, Catheters as well as extrusions, catheter shafts and medical balloons
Interface Catheter Solutions
Balloon Catheters
STERIS Isomedix Services
Provides sterilization and validation services using gamma irradiation, ethylene oxide and steam sterilization technologies through 19 North American locations
Resonetics
Polymer Micromachining
Emergo Group, Inc.
Regulatory charts and consulting
Instron
Precision testing instrumentation and services for materials, components, and structures in R&D, Quality Control and Production environments.
RBC Medical Innovations
RBC is also the exclusive provider of AdvantageRF - a portfolio of flexible mix and match solution tools for RF product developers that reduce risks, enhance reliability and sustainability, as well as accelerate time to market and lower R & D costs.
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp